SCYNEXIS INC (SCYX) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $30 million, SCYNEXIS INC is a micro-cap company. The stock currently trades at $0.74, down 1.05% today, with a 52-week range of $0.56–$1.31.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.44 | $-0.44 | -131.7% | |
| 2023 | $1.39 | $1.40 | +194.6% | |
| 2022 | $-1.47 | $-1.47 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | $-1.58 | $-1.58 | +41.0% | |
| 2015 | $-2.68 | $-2.68 | +0.4% | |
| 2014 | $-2.69 | $-1.04 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-12 | 0000950170-25-038044 | SEC ↗ |
| 2023-12-31 | 2024-03-28 | 0000950170-24-038046 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0000950170-23-011138 | SEC ↗ |
| 2021-12-31 | 2022-03-29 | 0001564590-22-012199 | SEC ↗ |
| 2020-12-31 | 2021-03-29 | 0001564590-21-015962 | SEC ↗ |
| 2019-12-31 | 2020-03-11 | 0001564590-20-009875 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001564590-19-007834 | SEC ↗ |
| 2017-12-31 | 2018-03-13 | 0001564590-18-005461 | SEC ↗ |
| 2016-12-31 | 2017-03-13 | 0001178253-17-000001 | SEC ↗ |
| 2015-12-31 | 2016-03-07 | 0001178253-16-000144 | SEC ↗ |
| 2014-12-31 | 2015-03-30 | 0001178253-15-000034 | SEC ↗ |